Catalyst

Slingshot members are tracking this event:

Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients with Cystic Fibrosis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PTI Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 01, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Fda, Fast Track Designation, Pti-428, Cystic Fibrosis, Transmembrane Conductance Regulator, Cftr Modulator